Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
This Management’s Discussion and Analysis
of Financial Condition and Results of Operations contain certain forward-looking statements. Historical results may not indicate future
performance. Our forward-looking statements reflect our current views about future events; are based on assumptions and are subject to
known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements.
Factors that may cause differences between actual results and those contemplated by forward-looking statements include, but are not limited
to, those discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2020.
We undertake no obligation to publicly update or revise any forward-looking statements, including any changes that might result from any
facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Furthermore, we cannot guarantee
future results, events, levels of activity, performance, or achievements
Basis of Presentation
The unaudited condensed consolidated financial
information presented below and the following Management Discussion and Analysis of the Consolidated Financial Condition, Results of Operations,
Stockholders’ Equity and Cash Flow for the quarterly periods ended June 30, 2021 and 2020 gives effect to our acquisition of OXYS
Corporation (“ OXYS ”) on July 28, 2017. In accordance with the accounting reporting requirements for the recapitalization
related to the “reverse merger” of OXYS, the financial statements for OXYS have been adjusted to reflect the change in the
shares outstanding and the par value of the common stock of OXYS. Additionally, all intercompany transactions between the Company and
OXYS have been eliminated.
Forward-Looking Statements
Statements in this management’s discussion
and analysis of financial condition and results of operations contain certain forward-looking statements. To the extent that such statements
are not recitations of historical fact, such statements constitute forward looking statements which, by definition involve risks and uncertainties.
Where in any forward-looking statements, if we express an expectation or belief as to future results or events, such expectation or belief
is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation or
belief will result or be achieved or accomplished.
Factors that may cause differences between actual
results and those contemplated by forward-looking statements include those discussed in “Risk Factors” found in our Annual
Report on Form 10-K for the year ended December 31, 2020, filed with the U.S. Securities and Exchange Commission (the “ SEC ”)
on April 6, 2021, and are not limited to the following:
·
the unprecedented impact of COVID-19 pandemic on our business, customers, employees, subcontractors and supply chain, consultants, service providers, stockholders, investors and other stakeholders;
·
general market and economic conditions;
·
our ability to maintain and grow our business with our current customers;
·
our ability to meet the volume and service requirements of our customers;
·
industry consolidation, including acquisitions by us or our competitors;
·
capacity utilization and the efficiency of manufacturing operations;
·
success in developing new products;
·
timing of our new product introductions;
·
new product introductions by competitors;
·
the ability of competitors to more fully leverage low-cost geographies for manufacturing or distribution;
·
product pricing, including the impact of currency exchange rates;
·
effectiveness of sales and marketing resources and strategies;
·
adequate manufacturing capacity and supply of components and materials;
·
strategic relationships with our suppliers;
·
product quality and performance;
·
protection of our products and brand by effective use of intellectual property laws;
·
the financial strength of our competitors;
·
the outcome of any future litigation or commercial dispute;
·
barriers to entry imposed by competitors with significant market power in new markets;
·
government actions throughout the world; and
·
our ability to service secured debt, when due.
26
You should not rely on forward-looking statements
in this document. This management’s discussion contains forward looking statements that involve risks and uncertainties. We use
words such as “anticipates,” “believes,” “plans,” “expects,” “future,” “intends,”
and similar expressions to identify these forward-looking statements. Prospective investors should not place undue reliance on these statements,
which apply only as of the date of this document. Our actual results could differ materially from those anticipated in these forward-looking
statements.
Critical Accounting Policies
The following discussions are based upon our financial
statements, which have been prepared in accordance with accounting principles generally accepted in the United States. These financial
statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States.
The preparation of these financial statements
requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and
expenses, and related disclosures of contingencies. We continually evaluate the accounting policies and estimates used to prepare the
financial statements. We base our estimates on historical experiences and assumptions believed to be reasonable under current facts and
circumstances. Actual amounts and results could differ from these estimates made by management.
Trends and Uncertainties
On July 28, 2017, we closed the reverse acquisition
transaction under the Securities Exchange Agreement dated March 16, 2017, as reported in our Current Report on Form 8-K filed with the
Commission on August 3, 2017. Following the closing, our business has been that of OXYS, Inc. and HereLab, Inc., our wholly-owned subsidiaries.
Our operations have varied significantly following the closing since, prior to that time, we were an inactive shell company.
Impact of COVID-19
During the year 2020, the effects of a new coronavirus
(“ COVID-19 ”) and related actions to attempt to control its spread began to impact our business. The impact of COVID-19
on our operating results for the six months ended June 30, 2021 limited our ability to obtain new business, in all material respects,
due to the government mandated numerous measures, including closures of businesses, limitations on movements of individuals and goods,
and the imposition of other restrictive measures, in its efforts to mitigate the spread of COVID-19 within the country.
On March 11, 2020, the World Health Organization
designated COVID-19 as a global pandemic. Governments around the world have mandated, and continue to introduce, orders to slow the transmission
of the virus, including but not limited to shelter-in-place orders, quarantines, significant restrictions on travel, as well as work restrictions
that prohibit many employees from going to work. Uncertainty with respect to the economic effects of the pandemic has introduced significant
volatility in the financial markets.
Historical Background
We were incorporated in the State of New Jersey
on October 1, 2003 under the name of Creative Beauty Supply of New Jersey Corporation, and subsequently changed our name to Gotham Capital
Holdings, Inc. on May 18, 2015. We commenced operations in the beauty supply industry as of January 1, 2004. On November 30, 2007, our
Board of Directors approved a plan to dispose of our wholesale and retail beauty supply business. From January 1, 2009 until July 28,
2017, we had no operations and were a shell company.
On March 16, 2017, our Board of Directors adopted
resolutions, which were approved by shareholders holding a majority of our outstanding shares, to change our name to “IIOT-OXYS,
Inc.”, to authorize a change of domicile from New Jersey to Nevada, to authorize a 2017 Stock Awards Plan, and to approve the Securities
Exchange Agreement (the “ OXYS SEA ”) between the Company and OXYS Corporation (“ OXYS ”), a Nevada
corporation incorporated on August 4, 2016.
Under the terms of the OXYS SEA we acquired 100%
of the issued voting shares of OXYS in exchange for 34,687,244 shares of our Common Stock. We also cancelled 1,500,000 outstanding shares
of our Common Stock and changed our management to Mr. DiBiase who also served in management of OXYS. Also, one of our principal shareholders
entered into a consulting agreement with OXYS to provide consulting services during the transition. The OXYS SEA was effective on July
28, 2017, and our name was changed to “IIOT-OXYS, Inc.” at that time. Effective October 26, 2017, our domicile was changed
from New Jersey to Nevada.
27
On December 14, 2017, we entered into a Share
Exchange Agreement (the “ HereLab SEA ”) with HereLab, Inc., a Delaware corporation (“ HereLab ”), and
HereLab’s two shareholders pursuant to which we would acquire all the issued and outstanding shares of HereLab in exchange for the
issuance of 1,650,000 shares of our Common Stock, on a pro rata basis, to HereLab’s two shareholders. The closing of the transaction
occurred on January 11, 2018 and HereLab became our wholly-owned subsidiary.
A new management team was put into place in 2018,
which constitutes our current management team.
At the present time, we have two, wholly-owned
subsidiaries which are OXYS Corporation and HereLab, Inc., through which our operations are conducted.
General Overview
IIOT-OXYS, Inc., a Nevada corporation (the “ Company ”),
and OXYS, were originally established for the purposes of designing, building, testing, and selling Edge Computing systems for the Industrial
Internet. Both companies were, and presently are, early-stage technology startups that are largely pre-revenue in their development
phase. HereLab is also an early-stage technology development company. The Company received its first revenues in the last
quarter of 2017, has continued to realize revenues in 2020, and didn’t realize revenue growth in 2021 once the pandemic hit.
We develop hardware, software and algorithms that
monitor, measure and predict conditions for energy, structural, agricultural and medical applications. We use domain-specific Artificial
Intelligence to solve industrial and environmental challenges. Our engineered solutions focus on common sense approaches to machine learning,
algorithm development and hardware and software products.
Our customers have issues and they need improvements.
We design a system of hardware and software, assemble, install, monitor data and apply our algorithms to help provide the customer insights.
We use off the shelf components, with reconfigurable
hardware architecture that adapts to a wide range of customer needs and applications. We use open-source software tools, while still creating
proprietary content for customers, thereby reducing software development time and cost. The software works with the hardware to collect
data from the equipment or structure that is being monitored.
We focus on developing insights. We develop algorithms
that help our customers create insights from vast data streams. The data collected is analyzed and reports are created for the customer.
From these insights, the customer can act to improve their process, product or structure.
Results of Operations for the Three Months
Ended June 30, 2021 compared to the Three Months Ended June 30, 2020
For the three months ended June 30, 2021, the
Company did not earn any revenues. The Company incurred professional fees of $165,341, interest expense of $110,891, payroll expense of
$96,598, amortization of intangible assets of $12,341, and other general and administrative expenses (“ G&A ”) of
6,993, offset by a gain on change in fair market value of derivative liability of $105,961. As a result, the Company incurred a net loss
of $286,203 for the three months ended June 30, 2021.
Comparatively, for the three months ended June
30, 2020, the Company earned revenues of $26,171 and incurred related cost of sales of $12,487. The Company incurred professional fees
of $244,216, interest expense of $49,434, amortization of intangible assets of $12,341, G&A expenses of $17,037, and a loss on change
in fair market value of derivative liability of $75,324. As a result, the Company incurred a net loss of $384,668 for the three months
ended June 30, 2020.
Results of Operations for the Six Months
Ended June 30, 2021 compared to the Six Months Ended June 30, 2020
For the six months ended June 30, 2021, the Company
did not earn any revenues. The Company incurred professional fees of $376,496, interest expense of $232,338, payroll expense of $138,279,
amortization of intangible assets of $24,818, and G&A expenses of $14,440, offset by gain on extinguishment of debt of $120,000 and
gain on change in the fair market value of derivative liability of $190,661. As a result, the Company incurred a net loss of $475,710
for the six months ended June 30, 2021.
28
Comparatively, for the six months ended June 30,
2020, the Company earned revenues of $41,771 and incurred related cost of sales of $21,121. The Company incurred professional fees of
$431,337, interest expense of $567,723, amortization of intangible assets of $24,682, other G&A expenses of $32,223, loss on change
in the fair market value of derivative liability of $139,232, partially offset by miscellaneous income of $409. As a result, the Company
incurred a net loss of $1,174,138 for the six months ended June 30, 2020.
Year over Year (YoY) revenue for the three months
ended June 30, 2021 was less than in same period of 2020. This was due to longer than anticipated customer acquisition times. This factor
resulted in a challenging quarter relative to generating revenue. Our Annual Report on Form 10-K for the year ended December 31, 2020
disclosed risks of ongoing concerns, and those concerns still exist.
A counterbalance to the revenue headwinds is the
achievements we have made.
Year to Date, in 2021
·
We have entered into a total of four NDAs with two New England Biotech companies, one Biomedical company, and one South American Structural Health Monitoring company. Our customer engagement process consists of several steps, the first being the execution of an NDA, which then allows us to quickly define a problem statement of interest to the client, which then leads to a definition of scope of work for the first contract. We expect these agreements to lead to new business in due time.
·
We have entered into NDAs with two major New England Universities to pursue an NSF grant associated with our Structural Health Monitoring expertise.
·
We have secured significant and supportive funding, which has supported ongoing operations in Q1, Q2, and most recently Q3.
·
We named a new interim CTO, emphasizing our focus on the Artificial Intelligence (AI) and Machine Learning (ML) aspects of our business. The interim CTO successfully completed his term and will continue to provide technical guidance as Advisory Board Chairman. Our CEO, as part of his responsibilities, will assume the duties of CTO until we finalize a successor.
·
We have rebuilt our Advisory Board with two new members, our former CTO who will serve as a technical advisor and overall leader of the Advisory Board, and the second with a strong legal and business background.
We believe the underlying strengths of the Company
are still in place: an experienced leadership team; contributions of our former interim CTO (and now Advisory Board Chairman) leading
our technology team, an MIT PhD level Machine Learning Algorithm Engineer; and strong execution on contracts to date. Those completed
contracts to date have produced two successful pilot programs: one on manufacturing operations for our Fortune 500 Pharma customer, and
a pilot with a full year of data collection and analysis on our structural health monitoring program for a New England state’s DOT.
Our continued focus on high potential growth markets (specifically Biotech, Pharma, and Medical Device Operations, as well as Structural
Health Monitoring), have yielded numerous prospects for future growth. Furthermore, the strength of our target market, the Industrial
Internet of Things (IIoT), continues: Market research shows the worldwide IIoT market in 2020 was $77.3 billion USD and is projected to
be $110.6 billion USD by 2025 (7.4% CAGR). [1]
It is anticipated that revenue will be generated
in the second half of 2021, yielding YoY revenue growth that will exceed that for the same period of 2020. This is due to the hard work
of the past year that has resulted in two successful pilots, in two of our key target industry verticals. We now have data and algorithms
to build strong use cases and marketing collateral that can be leveraged to extend contracts with current customers and win additional
contracts with new customers in all targeted industry segments. Also, the strength of the Aingura IIoT, S.G. collaboration agreement has
bolstered financial stability, added talent breadth and depth, and complimentary industry segment experience. We recently announced our
partner, Aingura IIoT, S.L., won an initial contract with ArcelorMittal, the largest steel manufacturer in North America, South America,
and Europe and is further evidence of this collaboration’s value. Furthermore, the continued liquidity of our stock has attracted
funding opportunities, and access to additional capital has and will enable funding of business development, staff augmentation, and inorganic
growth opportunities. Combined with our underlying strengths: experienced leadership; savvy technological talent, and operational execution
excellence; we believe these revenue goals are achievable.
[1]
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=129733727
29
Liquidity and Capital Resources
At June 30, 2021, the Company reported a cash
balance of $80,262, which represents a $22,812 decrease from the $103,074 balance at December 31, 2020. This decrease in cash was primarily
the result of cash used in operating activities of $394,722 offset by the cash proceeds received from sale of common stock of $371,910,
net of commissions. At June 30, 2020, the Company reported a cash balance of $34,032.
Operating Activities
Net cash used in operating activities for the
six months ended June 30, 2021 was $394,722, primarily as a result of our net loss of $486,778, gain on extinguishment of debt of $120,000,
beneficial conversion feature discount on notes payable of $360,000, amortization of debt discount of $172,595, amortization of intangible
assets of $24,818, and change is operating assets and liabilities of $167 due to increase in prepaid expense of $4,379, accounts payable
of $4,437, accrued liabilities of $55,165, shares payable to related parties of $274,790, offset by decrease in derivative liability of
$190,661, and salaries payable to related parties of $139,519.
Net cash used in operating activities for the
six months ended June 30, 2020 was $56,390, primarily as a result of our net loss of $1,174,138, loss on issuance of default warrants
of $163,433, increase in penalty due to penalty provisions of $146,250, increase in principal due to fees of $16,726, amortization of
discount on notes payable of $47,490, amortization of intangible assets of $24,682, and change in operating assets and liabilities of
$719,167 due to increase in prepaid expense of $325, derivative liability of $299,120, deferred revenues of $46,425, shares payable to
related parties of $362,454 and salaries payable to related parties of $12,863, offset by decrease in accounts receivable of $11,760,
accounts payable of $420, and accrued liabilities of $12,710.
Investing Activities
Net cash used in investing activities for the
six months ended June 30, 2021 and 2020, was $0.
Financing Activities
Net cash provided by financing activities for
the six months ended June 30, 2021 was $371,910 consisting of cash proceeds from sale of common stock of $371,910, net of commissions
paid of $7,590.
Net cash provided by financing activities for
the six months ended June 30, 2020 was $66,210 consisting of cash received from Payroll Protection Program of $36,700 and cash received
from convertible note payable of $29,510.
The accompanying financial statements have been
prepared assuming the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has incurred
losses from operations of $486,778 and $1,174,138 for the six months ended June 30, 2021 and 2020, respectively, and has an accumulated
deficiency which raises substantial doubt about the Company’s ability to continue as a going concern.
Management believes the Company will continue
to incur losses and negative cash flows from operating activities for the foreseeable future and will need additional equity or debt financing
to sustain its operations until it can achieve profitability and positive cash flows. Management plans to seek additional debt and/or
equity financing for the Company but cannot assure that such financing will be available on acceptable terms. At the Company’s current
rate of expenditure, the Company anticipates that it not be able to maintain its current operations for the next twelve months; however,
management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of
equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable
operations.
The Company’s continuation as a going concern
is dependent upon its ability to ultimately attain profitable operations, generate sufficient cash flow to meet its obligations, and obtain
additional financing as may be required. Our auditors have included a going concern qualification in their auditors’ report dated
April 6, 2021. Such a going concern qualification may make it more difficult for us to raise funds when needed. The outcome of this uncertainty
cannot be assured.
30
The accompanying unaudited condensed consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty. There can be no assurance
that management will be successful in implementing its business plan or that the successful implementation of such business plan will
actually improve the Company’s operating results.
Recently Issued Accounting Standards
Management does not believe that any other recently
issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying financial statements.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements
that have or are reasonably likely to have a current or future material effect on our consolidated financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity capital expenditures or capital resources.
Emerging Growth Company
We are an “emerging growth company,”
as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Certain specified reduced reporting and other regulatory
requirements that are available to public companies that are emerging growth companies. These provisions include:
1.
an exemption from the auditor attestation requirement in the assessment of our internal controls over financial reporting required by Section 404 of the Sarbanes-Oxley Act of 2002;
2.
an exemption from the adoption of new or revised financial accounting standards until they would apply to private companies;
3.
an exemption from compliance with any new requirements adopted by the Public Company Accounting Oversight Board, or the PCAOB, requiring mandatory audit firm rotation or a supplement to the auditor’s report in which the auditor would be required to provide additional information about our audit and our financial statements; and
4.
reduced disclosure about our executive compensation arrangements.
We have elected to take advantage of the exemption
from the adoption of new or revised financial accounting standards until they would apply to private companies. As a result of this election,
our financial statements may not be comparable to public companies required to adopt these new requirements.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
As a smaller reporting company, the Company has
elected not to provide the disclosure required by this item.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.